Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Norepinephrine is a vasopressor agent that is scientifically validated for the treatment and support of various types of shock, particularly septic shock. Its use is supported by robust evidence and is recommended in major clinical guidelines, such as those from the Surviving Sepsis Campaign and the American College of Critical Care Medicine.

The primary mechanism of action of norepinephrine is its potent alpha-adrenergic agonist effect, which leads to vasoconstriction, thereby increasing systemic vascular resistance and raising blood pressure. It also has some beta-adrenergic effects, which can increase cardiac output, though this is less pronounced than its vasoconstrictive properties.

Numerous randomized controlled trials and observational studies have demonstrated that norepinephrine is effective in restoring and maintaining blood pressure in patients with shock, and is associated with better outcomes compared to other vasopressors such as dopamine. For example, the landmark SOAP II trial (N Engl J Med. 2010;362:779-789) found that norepinephrine was associated with lower rates of arrhythmias and similar or better mortality outcomes compared to dopamine in shock patients. Current international guidelines recommend norepinephrine as the first-line vasopressor for septic shock because of this strong evidence base.

In summary, the use of norepinephrine for the support and treatment of shock is firmly established by high-quality scientific evidence.

More about Norepinephrine
More about Shock

Other ingredients used for Shock

Other health conditions supported by Norepinephrine

Products containing Norepinephrine